Fatal Noncutaneous Visceral Infection with Varicella-Zoster Virus in a Patient with Lymphoma after Autologous Bone Marrow Transp
Patients with cancer achieve response to messenger RNA COVID-19 vaccine
Durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: Three-month follo
The Influence of Mucositis on Oral Thermometry: When Fever May Not Reflect Infection
Metastatic Salivary Gland Tumors: A Single-Center Study Demonstrating the Feasibility and Potential Clinical Benefit of Molecular-Profiling-Guided Therapy
Cancers | Free Full-Text | Comparison of Poly (ADP-ribose) Polymerase Inhibitors (PARPis) as Maintenance Therapy for Platinum-Sensitive Ovarian Cancer: Systematic Review and Network Meta-Analysis
Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast can
Clinical effectiveness of seasonal influenza vaccine among adult cancer patients
A phase I clinical trial of dTCApFs, a derivative of a novel human hormone peptide, for the treatment of advanced/metastatic sol
White Matter Changes in Patients with Breast Cancer Treated with High-Dose Chemotherapy and Autologous Bone Marrow Support
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) - Annals of Oncology
Stability and Transitions in Posttraumatic Growth Trajectories Among Cancer Patients: LCA and LTA Analyses
ESMO Congress 2021 Speakers Template
Pasireotide for malignant insulinoma
NBER WORKING PAPER SERIES WHY IS END-OF-LIFE SPENDING SO HIGH? EVIDENCE FROM CANCER PATIENTS Dan Zeltzer Liran Einav Amy Finkels
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy | npj Breast Cancer
Pharmaceuticals | Free Full-Text | Tumor-Targeted Fluorescent Proteinoid Nanocapsules Encapsulating Synergistic Drugs for Personalized Cancer Therapy
Feasibility and low toxicity of early radiotherapy after highâ•'dose chemotherapy and autologous stem cell transplantation
Collaterals
Trajectories of Injectable Cancer Drug Costs After Launch in the United States | Journal of Clinical Oncology
Phase II organâ•'preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to
This gives hope': A third COVID-19 vaccine dose can boost protection for organ transplant recipients | Science | AAAS
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer | NEJM
Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry | npj Breast Cancer
Staphylococcus Coagulase‐Positive Skin Inflammation Associated with Epidermal Growth Factor Receptor‐Targe
NBER on Twitter: "Sources of high end-of-life spending for cancer patients, from @danzeltzer, Liran Einav, Amy Finkelstein, Tzvi Shir, Salomon M. Stemmer, and Ran D. Balicer https://t.co/vyosdFbT3M https://t.co/VsajwVZKrx" / Twitter
